Following Robert Wessman’s departure as CEO, a number of changes in senior management have taken place at the generic pharmaceuticals manufacturer.
Actavis Group, the international generic drug company, has announced that it has appointed Gudbjorg Edda Eggertsdottir as Deputy CEO.
Valur Ragnarsson will become the new Executive Vice President of Third-Party Sales and Doug Boothe will be [...]

Popularity: 5% [?]

The Iceland-based generic drugs manufacturer Actavis announces the opening of a new disabled access ramp to a major Bulgarian cathedral.
Actavis has financed the construction of an access ramp for disabled people to a large cathedral in Bulgaria. The ramp was officially opened by Nikolay Hadjidonchev, Actavis’ Bulgaria Managing director, in the presence of admiral Hristo [...]

Popularity: 10% [?]

Robert Wessman will speak on “The strategy and competitiveness of Actavis in a fiercely competitive environment” in London on Wednesday.

Actavis generic pharmaceuticals have announced that its President & CEO, Robert Wessman, will discuss “The strategy and competitiveness of Actavis in a fiercely competitive environment” at the annual UBS Global Specialty and Generic Pharmaceuticals Conference [...]

Popularity: 9% [?]

Generic pharmaceuticals company Actavis has signed an agreement with Generic Health in Australia.
Actavis in Australia has entered into an exclusive distribution agreement for a number of retail products with Generic Health, an Australian owned and operated generic pharmaceutical company headquartered in Melbourne, Australia.
The agreement is an important step in building Actavis’ presence in the Australian [...]

Popularity: 8% [?]

Actavis, the international generic pharmaceuticals company, has signed an agreement with the Zhejiang Chiral Medicine Chemicals Company in Hangzhou, China.
Actavis will take a 90% share in the Chinese company which specialises in research, development and production of active pharmaceutical ingredients (APIs). The acquisition is part of Actavis’ strategy to gain direct access to low cost [...]

Popularity: 9% [?]